Document is current
Any future updates will be listed below
-
Authors
Gunnarsson, N
Höglund, M
Stenke, L
Sandin, F
Björkholm, M
Dreimane, A
Lambe, M
Markevärn, B
Olsson-Strömberg, U
Wadenvik, H
Richter, J
Själander, A
- License Information
-
More Information
Article History
First Online: 2 May 2017
Competing interests
: FS has a consulting role for Biogen. JR has received honoraria from ARIAD, Bristol-Myers Squibb, Novartis and Pfizer and received research founding from Bristol-Myers Squibb and Novartis. MB has received research founding from Adolf H Lundin Charitable Foundation. MH has a consulting role for Akinion Pharmaceuticals and Janssen-Cilag. ML has stock ownership in AstraZeneca and Pfizer. UO-S received research founding and honoraria from Bristol-Myers Squibb. The remaining authors declare no competing financial interest.
